These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4832112)

  • 21. [A comparative test concerning the usability of the ventral prostate weight test and the ovarian ascorbic acid depletion test in the determination of the luteinizing hormone].
    de Groot CA
    Pharm Weekbl; 1966 Nov; 101(44):991-4. PubMed ID: 5981626
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of gonadotropic valency of preparations from pregnant mare's serum (PMSG). 3. Determination of the "PMSG-Substandard-Dessau" activity in follicle-stimulating hormone (FSH) and luteinizing hormone (LH) bioassays].
    Bergfeld J; Haring E
    Arch Exp Veterinarmed; 1983 Nov; 37(6):801-6. PubMed ID: 6422899
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of copper sulphate on pituitary LH in rats.
    Jelínek JM; Marhan O; Seda M
    Endocrinol Exp; 1970; 4(1):37-43. PubMed ID: 4938037
    [No Abstract]   [Full Text] [Related]  

  • 24. A new bioassay for luteinizing hormone.
    Rees LH; Holdaway IM; McNeilly AS; Chard T
    J Endocrinol; 1973 Jul; 58(1):18. PubMed ID: 4737337
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of in vitro bioassays for the estimation and characterization of human luteinizing hormone (LH).
    Khan SA; Qazi MH; Diczfalusy E
    J Endocrinol Invest; 1984; 7 Suppl 3():1-22. PubMed ID: 6399296
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of gestagens on the effects of LH on the rat ovary. Ascorbic acid content].
    Neumann HO; Uhlarik A; Schwalbach K
    Arch Gynakol; 1971 Jun; 211(1):236-7. PubMed ID: 5108863
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the action of the hypothalamic LRF factor (LH-releasing factor) in the rat in vivo and in vitro].
    Jutisz M; Bérault A; Novella MA; Ribot G
    Acta Endocrinol (Copenh); 1967 Jul; 55(3):481-96. PubMed ID: 6072063
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences with Parlow's ascorbic acid test].
    Breckwoldt M; Czygan PJ
    Z Geburtshilfe Gynakol; 1967 Oct; 167(3):329-36. PubMed ID: 5597696
    [No Abstract]   [Full Text] [Related]  

  • 29. [The mechanism of action of synthetic antiovular drugs. Experimental studies with mestranol, medroxyprogesterone and norethindrone].
    Oppo GT; Barbanti-Silva C; Segre A
    Riv Ital Ginecol; 1968 May; 52(5):389-410. PubMed ID: 5740572
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of luteinizing hormone and vasopressin injected into the ovarian bursa on ovarian ascorbic acid concentration.
    Ishii S
    Endocrinol Jpn; 1971 Jun; 18(3):263-6. PubMed ID: 5172023
    [No Abstract]   [Full Text] [Related]  

  • 31. INFLUENCE OF SERUM ON THE PROSTATE ASSAY OF LUTEINIZING HORMONE (LH, ICSH).
    PARLOW AF
    Endocrinology; 1963 Oct; 73():456-61. PubMed ID: 14068832
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of ascorbic acid and estrogens on cathepsin activity of human ovarian tissue].
    Niedner W; Wagner F; Hofmann KD; Preibsch W
    Zentralbl Gynakol; 1973 Feb; 95(8):247-52. PubMed ID: 4697127
    [No Abstract]   [Full Text] [Related]  

  • 33. [STUDIES ON DEPLETION OF OVARIAN VITAMIN C AND CHOLESTEROL].
    FRANCHIMONT P
    Ann Endocrinol (Paris); 1964; 25():195-206. PubMed ID: 14163479
    [No Abstract]   [Full Text] [Related]  

  • 34. Some observations on the dose-response curve of the ovarian ascorbic acid depletion test for luteinizing hormone.
    Bell ET; Mukerji S
    J Endocrinol; 1965 Oct; 33(2):325-6. PubMed ID: 5891675
    [No Abstract]   [Full Text] [Related]  

  • 35. [DETERMINATION OF LUTEINIZING HORMONE IN HUMAN PLASMA. RESULTS IN NORMAL SUBJECTS OF BOTH SEXES].
    LOUCHART J; TRUFFERT J; DECOURT J
    Acta Endocrinol (Copenh); 1965 Jun; 49():293-8. PubMed ID: 14303259
    [No Abstract]   [Full Text] [Related]  

  • 36. A modification of the OAAD test for luteinizing hormone for clinical purposes.
    Mondina R; Polvani F
    Acta Endocrinol (Copenh); 1970 Apr; 63(4):609-17. PubMed ID: 5468282
    [No Abstract]   [Full Text] [Related]  

  • 37. Short excitation wavelength fluorometric detection in high-pressure liquid chromatography of indole peptide, naphthyl, and phenol compounds.
    Krol GJ; Mannan CA; Pickering RE; Amato DV; Kho BT; Sonnenschein A
    Anal Chem; 1977 Oct; 49(12):1836-9. PubMed ID: 900507
    [No Abstract]   [Full Text] [Related]  

  • 38. [Advances and problems in estrogen measurement].
    Kambegawa A
    Horumon To Rinsho; 1969 Apr; 17(4):300-9. PubMed ID: 4897081
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism of action of luteinizing hormone.
    Flint AP; Denton RM
    Nat New Biol; 1972 Mar; 236(63):54-5. PubMed ID: 4401713
    [No Abstract]   [Full Text] [Related]  

  • 40. A colorimetric method for determination diethylaminoethyl ester of acetylsalicylic acid in biological materials.
    Bolanowska W; Skretkowicz J; Szunejko E
    Mater Med Pol; 1977; 9(1):19-21. PubMed ID: 875448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.